메뉴 건너뛰기




Volumn 41, Issue 10, 2008, Pages 905-906

Eighteen-year follow-up of the first Italian MPSI patient treated with bone marrow transplantation

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GLYCOSAMINOGLYCAN; LEVO IDURONIDASE; STEROID;

EID: 44449129111     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705988     Document Type: Letter
Times cited : (6)

References (4)
  • 1
    • 0000869162 scopus 로고    scopus 로고
    • The Mucopolysaccharidoses
    • Scriver CR, Beaudet AL, Sly WS, Valle D eds, 8th edn, McGraw-Hill: New York
    • Neufeld EF, Muenzer J. The Mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds). The Metabolic and Molecular Bases of Inherited Disease, 8th edn, vol. III. McGraw-Hill: New York, 2001, pp 3421-3452.
    • (2001) The Metabolic and Molecular Bases of Inherited Disease , vol.3 , pp. 3421-3452
    • Neufeld, E.F.1    Muenzer, J.2
  • 2
    • 0019466750 scopus 로고
    • Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation
    • Hobbs JR, Hugh-Jones K, Barrett AJ, Byrom N, Chambers D, Henry K et al. Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation. Lancet 1981; 2: 709-712.
    • (1981) Lancet , vol.2 , pp. 709-712
    • Hobbs, J.R.1    Hugh-Jones, K.2    Barrett, A.J.3    Byrom, N.4    Chambers, D.5    Henry, K.6
  • 3
    • 0037295890 scopus 로고    scopus 로고
    • Hematopoietic cell transplantation for inherited metabolic diseases: An overview of outcomes and practice guidelines
    • Peters C, Steward CG. Hematopoietic cell transplantation for inherited metabolic diseases: An overview of outcomes and practice guidelines. Bone Marrow Transplant 2003; 31: 229-239.
    • (2003) Bone Marrow Transplant , vol.31 , pp. 229-239
    • Peters, C.1    Steward, C.G.2
  • 4
    • 17144399564 scopus 로고    scopus 로고
    • The first 5 years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I
    • Wraith JE. The first 5 years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I. Expert Opin Pharmacother 2005; 6: 489-506.
    • (2005) Expert Opin Pharmacother , vol.6 , pp. 489-506
    • Wraith, J.E.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.